Close this search box.

AfPA Policy Collaborative

Together, AfPA’s Policy Collaborative advocates work for a common purpose: To raise awareness about the harm caused by restrictive utilization management practices and to protect patient access to prescribed medicines.
Patients today struggle to access the medicines their health care provider prescribes—regardless of their disease, its severity or their state of health. That’s because profit-minded health plans and pharmacy benefit managers routinely use utilization management techniques to keep patients from filling their prescriptions.
AfPA’s Policy Collaborative exists to fight this trend and to protect patient access to FDA-approved, doctor-prescribed medications. AfPA’s Policy Collaborative joins advocates from across disease communities who recognize that patients are harmed by practices such as:
Arduous prior authorization requirements
Fail first or step therapy protocols
Limited formularies, specialty tiers and copay accumulators
Non-medical switching that disrupts continuity of care

Featured Resources

Who Decides?

Who Decides? How Pharmacy and Therapeutics Committees Impact Patient Access
Who Decides? How Prescription Drug Affordability Boards Impact Patient Access
Who Decides? Pharmacy Benefit Managers & Medication Access
Who Decides? How ICER Impacts Patient Access
Who Decides? Defining the Value of Medical Treatment

Advocacy Insights

Advocacy Insights: Copay Accumulators
Advocacy Insights: Prior Authorization
Advocacy Insights: Non-Medical Switching
Advocacy Insights: Step Therapy


Alternative Funding Programs
Sacrificing Quality for the QALY
Barriers to Patient Access: Copay Accumulator Adjustment Programs
Barriers to Patient Access: Non-Medical Switching
Barriers to Patient Access: Step Therapy
Barriers to Patient Access: Prior Authorization


How “Alternative” Rx Funding Programs Fail Patients